Endocrinol Metab.  2018 Dec;33(4):466-472. 10.3803/EnM.2018.33.4.466.

Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country

Affiliations
  • 1Department of Medicine, San Juan de Dios Hospital and University of Talca, Curico, Chile.
  • 2Department of Endocrinology, Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile. lmosso@uc.cl
  • 3Department of Public Health, Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.
  • 4School of Public Health, Faculty of Medicine, University of Chile, Santiago, Chile.
  • 5Department of Family Medicine, Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.
  • 6Department of Pediatrics, Faculty of Medicine, Diego Portales University, Santiago, Chile.

Abstract

BACKGROUND
Thyroid dysfunction is associated with negative neonatal and obstetric outcomes. Large differences in thyroid function reference intervals exist across different populations. These differences can be explained by population-specific factors, such as iodine status. Many countries in Latin America report iodine sufficiency, but relatively few countries have published up-to-date data on iodine levels and thyroid function in the overall population, and especially in pregnant women. We evaluated the iodine status of pregnant women in Chile and determined thyroid hormone reference ranges in this population.
METHODS
This was a prospective observational study of healthy Chilean women at their first prenatal visit before week 14. Thyroid-stimulating hormone (TSH), total thyroxine (T4), free T4, antithyroid peroxidase antibody (TPOAb), and iodine levels from spot urine samples were measured. Iodine status and the reference ranges for TSH were calculated.
RESULTS
A total of 1,022 pregnant women in the first trimester were selected. Urinary iodine levels were measured in 302 randomly-selected women. The median urinary iodine concentration was 173.45 µg/L (interquartile range, 108.11 to 249.35).The reference ranges of TSH were calculated in 670 patients selected according to the National Academy of Clinical Biochemistry guidelines. The median TSH level was 1.88 µIU/mL (2.5th percentile: 0.13 to 97.5th percentile: 5.37). Using the reference range in the 1,022 women, the prevalence of clinical hypothyroidism was 1.76%, and that of subclinical hypothyroidism was 3.92%. TPOAb positivity was more common in women with TSH levels above 3.5 µIU/mL.
CONCLUSION
We found adequate iodine intake and a right-shifted distribution of serum TSH levels in pregnant women in Chile. The prevalence of hypothyroidism in our sample of pregnant women was higher than has been described in the literature.

Keyword

Pregnancy; Hypothyroidism; Thyroid; Iodine

MeSH Terms

Biochemistry
Chile
Female
Humans
Hypothyroidism
Iodine
Latin America
Observational Study
Peroxidase
Pregnancy
Pregnancy Trimester, First*
Pregnancy*
Pregnant Women
Prevalence
Prospective Studies
Reference Values*
Thyroid Gland
Thyrotropin*
Thyroxine
Iodine
Peroxidase
Thyrotropin
Thyroxine

Figure

  • Fig. 1 Flow diagram of patients. TPOAb, antithyroid peroxidase antibody; fT4, free thyroxine.

  • Fig. 2 Urinary iodine levels during the first trimester of pregnancy. Median urinary iodine level: 173.45 µg/L.

  • Fig. 3 Distribution of thyroid-stimulating hormone (TSH) levels (µIU/mL) in the first trimester of pregnancy in 1,022 women and differences in the prevalence of hypothyroidism using different cut-off points (2.5, 4.2, and 5.36 µIU/mL).

  • Fig. 4 Prevalence of positive antithyroid peroxidase antibody (TPOAb) according to thyroid-stimulating hormone (TSH) levels in pregnant women during the first trimester. aSignificant differences of anti-TPOAb prevalence with respect to the lowest prevalence within the normal range (5.66%; 95% confidence interval [CI], 2.03 to 9.29) in 1.51 to 2.0 TSH category. Prevalence in 3.01 to 3.50, 3.51 to 4.0, 4.01 to 4.50, 5.01 to 7.50, 7.51 to 10.00, and 10.01+; TSH groups are 13.16% (95% CI, 5.38 to 20.93), 17.02% (95% CI, 5.87 to 28.18), 22.22% (95% CI, 5.46 to 38.98), 34.04% (95% CI, 19.98 to 48.11), 46.15% (95% CI, 14.8 to 77.51), and 46.15% (95% CI, 14.8 to 77.51), respectively.


Cited by  3 articles

Thyroid-Stimulating Hormone Reference Ranges in Early Pregnancy: Possible Influence of Iodine Status
Tae Yong Kim
Endocrinol Metab. 2018;33(4):445-446.    doi: 10.3803/EnM.2018.33.4.445.

Response: Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country (Endocrinol Metab 2018;33:466–72, Carmen Castillo et al.)
Lorena Mosso
Endocrinol Metab. 2019;34(2):213-214.    doi: 10.3803/EnM.2019.34.2.213.

Letter: Thyroid-Stimulating Hormone Reference Ranges in the First Trimester of Pregnancy in an Iodine-Sufficient Country (Endocrinol Metab 2018;33:466-72, Carmen Castillo et al.)
Hyemi Kwon
Endocrinol Metab. 2019;34(1):93-94.    doi: 10.3803/EnM.2019.34.1.93.


Reference

1. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007; 92(8 Suppl):S1–S47. PMID: 17948378.
Article
2. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21:1081–1125. PMID: 21787128.
Article
3. Qaseem A, Snow V, Owens DK, Shekelle P. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010; 153:194–199. PMID: 20679562.
Article
4. Orito Y, Oku H, Kubota S, Amino N, Shimogaki K, Hata M, et al. Thyroid function in early pregnancy in Japanese healthy women: relation to urinary iodine excretion, emesis, and fetal and child development. J Clin Endocrinol Metab. 2009; 94:1683–1688. PMID: 19258403.
Article
5. Yan YQ, Dong ZL, Dong L, Wang FR, Yang XM, Jin XY, et al. Trimester- and method-specific reference intervals for thyroid tests in pregnant Chinese women: methodology, euthyroid definition and iodine status can influence the setting of reference intervals. Clin Endocrinol (Oxf). 2011; 74:262–269. PMID: 21044115.
Article
6. Marwaha RK, Chopra S, Gopalakrishnan S, Sharma B, Kanwar RS, Sastry A, et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG. 2008; 115:602–606. PMID: 18333941.
Article
7. Moon HW, Chung HJ, Park CM, Hur M, Yun YM. Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann Lab Med. 2015; 35:198–204. PMID: 25729721.
Article
8. Mosso L, Martinez A, Rojas MP, Margozzini P, Solari S, Lyng T, et al. Frequency of subclinical thyroid problems among women during the first trimester of pregnancy. Rev Med Chil. 2012; 140:1401–1408. PMID: 23677185.
9. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003; 13:3–126. PMID: 12625976.
10. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97:2543–2565. PMID: 22869843.
Article
11. Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014; 3:76–94. PMID: 25114871.
Article
12. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017; 27:315–389. PMID: 28056690.
Article
13. Li C, Shan Z, Mao J, Wang W, Xie X, Zhou W, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014; 99:73–79. PMID: 24276458.
Article
14. Shi X, Han C, Li C, Mao J, Wang W, Xie X, et al. Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: a cross-sectional study of 7190 pregnant women in China. J Clin Endocrinol Metab. 2015; 100:1630–1638. PMID: 25629356.
Article
15. Council on Environmental Health. Rogan WJ, Paulson JA, Baum C, Brock-Utne AC, Brumberg HL, et al. Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem. Pediatrics. 2014; 133:1163–1166. PMID: 24864180.
16. Kim WG, Kim WB, Woo G, Kim H, Cho Y, Kim TY, et al. Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015. Endocrinol Metab (Seoul). 2017; 32:106–114. PMID: 28116874.
Article
17. Muzzo S, Burgueno M, Carvajal F, Biolley E, Avendano M, Vargas S, et al. Iodine nutrition in school children of four census areas of Chile. Rev Med Chil. 1997; 125:1299–1304. PMID: 9609050.
18. EUthyroid. Laboratory method and statistical analysis for cross-lab comparison [Internet]. Vienna: Biolution GmbH;c2015. cited 2018 Nov 5. Available from: http://euthyroid.eu/download/EUthyroid_iodinemap_textEN.pdf.
19. World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination. 3rd ed. Geneva: World Health Organization;2007.
20. Muzzo S, Leiva L, Ramirez I, Carvajal F, Biolley E. Iodine nutrition status in school age children of an area of high iodine intake (Calama) compared with an area of normal intake (Punta Arenas). Rev Chil Nutr. 2005; 32:28–35.
21. Mioto VCB, Monteiro ACCNG, de Camargo RYA, Borel AR, Catarino RM, Kobayashi S, et al. High prevalence of iodine deficiency in pregnant women living in adequate iodine area. Endocr Connect. 2018; 7:762–767. PMID: 29700098.
Article
22. Medici M, Korevaar TI, Visser WE, Visser TJ, Peeters RP. Thyroid function in pregnancy: what is normal? Clin Chem. 2015; 61:704–713. PMID: 25829408.
Article
23. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid. 2004; 14:1084–1090. PMID: 15650363.
Article
24. Quinn FA, Gridasov GN, Vdovenko SA, Krasnova NA, Vodopianova NV, Epiphanova MA, et al. Prevalence of abnormal thyroid stimulating hormone and thyroid peroxidase antibody-positive results in a population of pregnant women in the Samara region of the Russian Federation. Clin Chem Lab Med. 2005; 43:1223–1226. PMID: 16232090.
Article
25. Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA, et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol. 2007; 157:509–514. PMID: 17893266.
Article
26. Korevaar TIM. The upper limit for TSH during pregnancy: why we should stop using fixed limits of 2.5 or 3.0 mU/l. Thyroid Res. 2018; 11:5. PMID: 29942352.
Article
27. Mosso L, Martinez A, Rojas MP, Latorre G, Margozzini P, Lyng T, et al. Early pregnancy thyroid hormone reference ranges in Chilean women: the influence of body mass index. Clin Endocrinol (Oxf). 2016; 85:942–948. PMID: 27260560.
Article
28. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab. 2007; 92:4236–4240. PMID: 17684054.
Article
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr